Specific Targeting of HER2 Overexpressing Breast Cancer Cells with Doxorubicin-Loaded Trastuzumab-Modified Human Serum Albumin Nanoparticles
Keyword(s):
2020 ◽
Vol 159
◽
pp. 137-153
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 7
(13)
◽
pp. 7101-7111
◽
2020 ◽
Vol 152
◽
pp. 90-101
◽
Keyword(s):
2016 ◽
Vol 35
(14)
◽
pp. 3012-3031
◽
Keyword(s):
2019 ◽
Vol 52
◽
pp. 652-659
◽
Keyword(s):
Keyword(s):
Keyword(s):